Research
Research

Routine imaging after double mastectomy for DCIS may be unnecessary, UCLA-led study finds

By Dr. Elena Voss ·

Why imaging after mastectomy may be redundant

Women who had both breasts removed to treat ductal carcinoma in situ (DCIS), a noninvasive form of breast cancer, likely do not need regular mammograms or other breast scans after surgery, according to new research from UCLA Health.

DCIS is classified as stage 0 breast cancer because it has not spread beyond the milk ducts. The study, led by investigators at the UCLA Jonsson Comprehensive Cancer Center, examined whether post-surgical imaging provides any clinical benefit for this patient group.

After a double mastectomy, there is no remaining breast tissue to screen. The research team concluded that routine mammography or other breast imaging does not improve outcomes for women with DCIS who have had both breasts removed.

What does this mean for patient care?

The finding challenges standard post-operative care protocols that often include periodic imaging. For DCIS patients, the absence of residual breast tissue means there is no target for screening.

The study suggests that clinicians can safely omit routine breast imaging for this specific patient population. This could reduce unnecessary medical procedures, lower patient anxiety, and cut healthcare costs.

However, the researchers note that individual patient factors, such as genetic risk or prior treatment complications, may still warrant case-by-case imaging decisions.

Frequently Asked Questions

Does this apply to all DCIS patients? The finding specifically targets women who underwent a double mastectomy. Patients with single mastectomy or those with invasive cancer may still require routine imaging.

Can patients skip all follow-up scans? Not entirely. While routine breast imaging may be unnecessary, patients should still attend clinical exams and address any new symptoms promptly.

Will insurers cover fewer scans now? The study provides evidence that may influence insurance policies, but changes depend on how quickly guidelines and payer rules are updated.